Amoxycillin & Potassium Clavulanate Inj. 150mg/300mg/1.2 Gm

What is Amoxycillin & Potassium Clavulanate Injection?

Amoxycillin and Potassium Clavulanate Injection is a combination antibacterial medicine containing amoxicillin, a penicillin-class antibiotic, and clavulanic acid, a beta-lactamase inhibitor. It is used for selected bacterial infections caused by susceptible organisms. The supplied presentations are listed as 150 mg, 300 mg and 1.2 gm, with a vial and water for injection (WFI) presentation as provided.

Uses / Indications
Amoxycillin and Potassium Clavulanate may be indicated for selected bacterial infections caused by susceptible organisms, depending on the approved formulation and local prescribing information.
Potential clinical applications may include:
– Selected respiratory tract infections.
– Certain skin and soft-tissue infections.
– Selected urinary tract infections.
– Other susceptible bacterial infections for which the specific injectable formulation is approved.
The exact indications depend on the approved product information, the causative organism and its susceptibility. This antibiotic combination is not effective against viral infections and should be used only when clinically indicated.
Benefits
– Complementary antibacterial activity: Amoxicillin inhibits bacterial cell-wall synthesis, while clavulanic acid helps inhibit certain beta-lactamase enzymes.
– Combination formulation: The two ingredients provide complementary actions against susceptible bacteria that produce certain beta-lactamases.
– Injectable presentation: The product is supplied in a vial presentation with WFI as specified; preparation must follow the approved instructions.
– Clinical application: May be suitable for specific infections requiring parenteral antibacterial treatment when supported by the approved product information.
The combination does not overcome every form of bacterial resistance and is not suitable for all infections.
Side Effects
Common Side Effects
Possible adverse effects associated with amoxicillin and clavulanate include:
– Nausea and vomiting.
– Diarrhoea or loose stools.
– Skin rash.
– Injection-site discomfort or inflammation, where applicable.
– Gastrointestinal discomfort.
The likelihood and severity of adverse effects depend on individual factors, the prescribed regimen and the specific product.
Less Common or Serious Side Effects
Clinically important adverse reactions may include:
– Severe allergic reactions, including anaphylaxis.
– Severe skin reactions.
– Antibiotic-associated colitis, including Clostridioides difficile-associated diarrhoea.
– Liver injury or cholestatic hepatitis.
– Blood-cell abnormalities, which are uncommon.
Urgent medical assessment is necessary if a severe allergic reaction, significant breathing difficulty, a serious skin reaction or persistent severe diarrhoea occurs.
How Does It Work?
Amoxicillin is a beta-lactam antibiotic that interferes with bacterial cell-wall synthesis by binding to penicillin-binding proteins. This weakens the bacterial cell wall and leads to antibacterial activity against susceptible organisms.
Clavulanic acid inhibits certain beta-lactamase enzymes that can otherwise break down amoxicillin. This protects amoxicillin against some enzyme-mediated resistance mechanisms. However, the combination is not active against every beta-lactamase-producing organism or every resistant bacterium.
Dosage Guidelines
The dosage and administration regimen must be determined by a qualified healthcare professional using the approved product information.
The appropriate regimen may depend on:
– The infection being treated and its severity.
– The prescribed strength and formulation.
– The patient’s age and body weight.
– Renal function and, where relevant, hepatic function.
– The susceptibility of the causative organism.
– The authorised administration route.
– Other medicines being taken.
The exact dose, administration route, frequency and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.
The listed strengths of 150 mg, 300 mg and 1.2 gm should be verified against the approved product specification to establish the exact component quantities and presentation. Do not assume that these figures represent identical component ratios or concentrations after reconstitution.
Antibacterial injections must be prepared and administered by appropriately trained healthcare professionals. Reconstitution volumes, diluent compatibility and administration instructions must be taken from the approved product documentation.
When Not to Use
Amoxycillin and Potassium Clavulanate may be contraindicated in patients with:
– A history of serious hypersensitivity to amoxicillin, clavulanate or relevant formulation components.
– A history of severe immediate hypersensitivity to other beta-lactam antibiotics, where specified by the approved product information.
– Previous amoxicillin/clavulanate-associated jaundice or hepatic dysfunction, where applicable to the product label.
Additional restrictions may apply depending on the patient’s medical history and the specific formulation. Allergy history and relevant hepatic and renal conditions should be assessed before treatment.
Drug / Product Interactions
Potentially relevant interactions include:
– Anticoagulants: Patients receiving oral anticoagulants may require appropriate monitoring because antibiotic treatment can affect anticoagulation control.
– Probenecid: May affect the elimination of amoxicillin.
– Methotrexate: Amoxicillin may affect methotrexate elimination and increase the risk of toxicity.
– Allopurinol: Concurrent use may increase the likelihood of skin reactions in some patients.
– Other medicines affecting renal function: Clinical assessment may be necessary depending on the patient’s condition and concomitant treatment.
The clinical relevance of these interactions depends on the individual medicines and patient factors. The complete medication list should be reviewed by the treating healthcare professional.
Safety Advice
– Use only for an appropriate bacterial infection when prescribed by a qualified healthcare professional.
– Confirm any history of penicillin or other relevant beta-lactam allergy before administration.
– Follow the approved preparation and administration instructions.
– Monitor for hypersensitivity reactions, gastrointestinal complications and other clinically relevant adverse effects.
– Assess renal function when required for dose selection.
– Consider hepatic precautions in patients with relevant medical histories.
– Use antibiotics responsibly to help limit antimicrobial resistance.
– Do not use a vial if its container integrity is compromised.
– If an overdose or administration error is suspected, seek immediate medical attention or contact an appropriate emergency medical service.
General Instructions
– Follow the prescribed dose and authorised administration route.
– Check the product name, label and expiry date before use.
– Use only the diluent and preparation method specified in the approved product information.
– Do not assume that the supplied WFI volume or reconstitution procedure is the same for every strength.
– Observe the approved storage and in-use conditions after preparation.
– Do not use the product if the container is damaged or its integrity is compromised.
– Dispose of unused medicine and associated materials according to applicable local requirements.
– Do not use after expiry.
Special Dietary / Lifestyle Tips
No specific dietary restriction is generally required unless advised by a healthcare professional. Patients should maintain appropriate fluid intake according to their clinical condition and the advice of their healthcare team.
Patients should report persistent diarrhoea, significant skin reactions or symptoms suggestive of an allergic reaction promptly. The full prescribed antibiotic course should be followed according to the treating healthcare professional’s instructions.
Comparison with Other Treatments
Treatment Type General Characteristics
Amoxicillin alone A penicillin-class antibiotic without the additional beta-lactamase inhibition provided by clavulanic acid.
Amoxycillin and Potassium Clavulanate Combines amoxicillin with clavulanic acid to address certain beta-lactamase-mediated resistance mechanisms.
Other beta-lactam antibiotics Have different antibacterial spectra, resistance profiles, indications and administration requirements.
Oral antibiotic presentations May be suitable for selected infections and patients, depending on the medicine and clinical circumstances.
Antibiotic selection should be based on the infection, organism susceptibility, local resistance patterns, patient factors and approved prescribing information. Injectable and oral formulations are not automatically interchangeable.
Precautions & Warnings
– Hypersensitivity: Assess the history of penicillin and other relevant beta-lactam allergies.
– Renal impairment: Dose adjustment may be necessary depending on renal function and the approved formulation.
– Hepatic impairment: Use caution in patients with a history of liver dysfunction, particularly where associated with amoxicillin/clavulanate.
– Pregnancy and breastfeeding: Use should be assessed by a healthcare professional according to the clinical need and approved product information.
– Paediatric and elderly patients: Selection and dosing require consideration of age, body weight, renal function and the specific formulation.
– Antibiotic-associated diarrhoea: Persistent or severe diarrhoea requires medical assessment.
– Antimicrobial resistance: Avoid inappropriate use and use the antibiotic only for suitable indications.
– Preparation and administration: Follow the product-specific instructions for WFI, reconstitution, compatibility and administration.
Can I Use It With Other Medicines?
Generally Compatible With
Other medicines may be used alongside amoxicillin/clavulanate when clinically appropriate. Compatibility depends on the individual medicines, the patient’s condition and the approved administration instructions.
Use With Caution / Avoid
Particular attention may be needed with anticoagulants, probenecid, methotrexate and other medicines identified in the approved product information.
Do not mix this injection with another medicine in the same syringe, vial or infusion container unless compatibility and preparation are explicitly supported by the approved product documentation.
Storage
Store according to the storage conditions stated on the approved product label and package insert.
– Keep in the original packaging where required.
– Protect from excessive heat and inappropriate light exposure where relevant.
– Follow the product-specific storage conditions after reconstitution.
– Keep out of reach of children.
– Do not use after expiry.
– Follow the approved in-use stability and disposal instructions.
Specific storage temperatures and stability periods after reconstitution are available on request and should be confirmed from the approved product documentation.
Frequently Asked Questions
1. What is Amoxycillin & Potassium Clavulanate Injection used for?
It is a combination antibacterial medicine used for selected bacterial infections caused by susceptible organisms. The approved indications depend on the specific formulation and product information.
2. What is the proposed trade name?
The proposed trade name is Amoclaventra. This is a suggested product name and does not imply trademark availability, registration or regulatory approval.
3. What type of antibiotic is this product?
It combines amoxicillin, a penicillin-class beta-lactam antibiotic, with clavulanic acid, a beta-lactamase inhibitor.
4. What strengths are listed for this product?
The supplied product details list 150 mg, 300 mg and 1.2 gm. The component quantities and precise presentation should be confirmed against the approved product specification.
5. Does the product require reconstitution?
The supplied presentation states “Vial With WFI”. The exact preparation method, diluent volume and any additional requirements must be confirmed from the approved instructions for the specific strength.
6. Can this injection interact with other medicines?
Yes. Interactions may occur with medicines such as anticoagulants, probenecid and methotrexate. A healthcare professional should review concomitant medicines before treatment.
7. What precautions apply to this injection?
Important precautions include relevant antibiotic allergies, renal and hepatic function, possible gastrointestinal adverse effects and correct preparation. It should be used under appropriate medical supervision.
8. How should this injection be stored?
Store according to the approved product label and package insert. Storage conditions after reconstitution should be confirmed for the specific product.